AAAAAA
Results: 76-100/390
Authors:
MEIJER P
VANDERHAM F
KLUFT C
Citation: P. Meijer et al., THE USE OF STABILYTE(R) PLASMA MAY CAUSE CHANGES IN PH IN THE ASSAY OF SOME FIBRINOLYSIS ANALYTES AND MIGHT EFFECT RESULTS, Fibrinolysis, 10, 1996, pp. 155-157
Authors:
ANDREOTTI F
PREVOST R
LUPI A
HAMILTON J
DEBART ACW
HUISMAN LGM
MASERI A
KLUFT C
Citation: F. Andreotti et al., CIRCADIAN PATTERNS OF PLASMA T-PA AND PAI-1 ANTIGEN LEVELS IN PATIENTS WITH SEVERE PERIPHERAL ATHEROSCLEROSIS, Fibrinolysis, 10, 1996, pp. 159-160
Authors:
BOTS ML
VANDERBOM JG
HAVERKATE F
MEIJER P
HOFMAN A
GROBBEE DE
KLUFT C
Citation: Ml. Bots et al., ACTIVATED PROTEIN-C RESPONSE AND CARDIOVASCULAR RISK-FACTORS IN THE ELDERLY - THE ROTTERDAM STUDY, Fibrinolysis, 10, 1996, pp. 161-164
Authors:
CLASON SB
MEIJER P
KLUFT C
ERSDAL E
Citation: Sb. Clason et al., A NOVEL METHOD, COAMATIC(R) PLASMIN INHIBITOR, FOR THE SPECIFIC DETERMINATION OF PLASMIN INHIBITOR ACTIVITY IN PLASMA, Fibrinolysis, 10, 1996, pp. 165-167
Authors:
HAVERKATE F
WALKER ID
CONKIE J
Citation: F. Haverkate et al., EXTERNAL QUALITY ASSESSMENT OF THROMBOPHILIA TESTING IN EUROPE, Fibrinolysis, 10, 1996, pp. 169-169
Authors:
KLUFT C
MEIJER P
Citation: C. Kluft et P. Meijer, UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP), Fibrinolysis, 10, 1996, pp. 171-179
Authors:
HOLMDAHL L
ERIKSSON E
RIPPE B
RISBERG B
Citation: L. Holmdahl et al., KINETICS OF TRANSPERITONEAL TISSUE-TYPE PLASMINOGEN-ACTIVATOR ABSORPTION, Fibrinolysis, 10(1), 1996, pp. 1-7
Authors:
JESPERSEN J
GRAM J
Citation: J. Jespersen et J. Gram, INCREASED FIBRIN FORMATION IN BLOOD IN WOMEN ABOVE THE AGE OF 30 WHO ARE BOTH ORAL-CONTRACEPTIVE USERS AND SMOKERS, Fibrinolysis, 10(1), 1996, pp. 9-13
Authors:
LEGNANI C
PALARETI G
LUDOVICI S
GASBARRINI A
BERNARDI M
COCCHERI S
Citation: C. Legnani et al., HYPERFIBRINOLYSIS BUT NOT HYPERCOAGULABILITY AFTER A NEW ASCITES-APHERESIS PROCEDURE IN LIVER-CIRRHOSIS PATIENTS WITH REFRACTORY ASCITES, Fibrinolysis, 10(1), 1996, pp. 15-20
Authors:
NOCI MV
VELASCO F
LOPEZ A
LOPEZPEDRERA R
RODRIGUEZ M
Citation: Mv. Noci et al., THE EFFECT OF EXOGENOUS NITRIC-OXIDE ON PLASMINOGEN-ACTIVATOR INHIBITOR IN EXPERIMENTALLY-INDUCED ENDOTOXEMIA, Fibrinolysis, 10(1), 1996, pp. 21-25
Authors:
JAMIESON A
ALCOCK P
TUFFIN DP
Citation: A. Jamieson et al., THE ACTION OF POLYANIONIC AGENTS DEFIBROTIDE AND PENTOSAN SULFATE ON FIBRINOLYTIC-ACTIVITY IN THE LABORATORY RAT, Fibrinolysis, 10(1), 1996, pp. 27-35
Authors:
SCHOBERSBERGER W
WIRLEITNER B
PUSCHENDORF B
KOLLER A
VILLIGER B
FREY W
MAIR J
Citation: W. Schobersberger et al., INFLUENCE OF AN ULTRAMARATHON RACE AT MODERATE ALTITUDE ON COAGULATION AND FIBRINOLYSIS, Fibrinolysis, 10(1), 1996, pp. 37-42
Authors:
CHORDA C
PARAMO JA
ROCHA E
Citation: C. Chorda et al., COMPARISON OF THE EFFECTS OF UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND HIRUDIN (REVASC(TM)) ON THE FIBRINOLYTIC POTENTIAL OFCULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS, Fibrinolysis, 10(1), 1996, pp. 43-48
Authors:
PIRIESHEPHERD SR
SERRANO RL
ANDON NL
GONZALEZGRONOW M
PIZZO SV
Citation: Sr. Pirieshepherd et al., THE ROLE OF CARBOHYDRATE IN THE ACTIVATION OF PLASMINOGEN-2 GLYCOFORMS BY STREPTOKINASE, Fibrinolysis, 10(1), 1996, pp. 49-53
Authors:
REVERDIAUMOALIC P
BILLAUD V
BODY G
LEBRANCHU Y
BARDOS P
GRUEL Y
Citation: P. Reverdiaumoalic et al., FIBRINOLYTIC STATUS OF THE NORMAL HUMAN FETUS - ASSOCIATION WITH UNDETECTABLE LEVELS OF HISTIDIN-RICH GLYCOPROTEIN AND LIPOPROTEIN(A), Fibrinolysis, 10(1), 1996, pp. 55-57
Authors:
DEAR AE
MEDCALF RL
Citation: Ae. Dear et Rl. Medcalf, THE CELLULAR AND MOLECULAR-BIOLOGY OF PLASMINOGEN-ACTIVATOR INHIBITORTYPE-2, Fibrinolysis, 9(6), 1995, pp. 321-330
Authors:
MISKIN R
ABRAMOVITZ R
Citation: R. Miskin et R. Abramovitz, ONE-PHASE REVERSE ZYMOGRAPHY AFTER DENATURING GEL-ELECTROPHORESIS - HIGH-SENSITIVITY DETECTION OF ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 AND OTHER PROTEASE INHIBITORS, Fibrinolysis, 9(6), 1995, pp. 331-342
Authors:
VANBOHEEMEN PA
VANDENHOOGEN CM
KOOLWIJK P
Citation: Pa. Vanboheemen et al., COMPARISON OF THE INHIBITION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ACTIVITY BY MONOCLONAL-ANTIBODIES SPECIFIC FOR U-PA AS ASSESSEDBY DIFFERENT ASSAYS, Fibrinolysis, 9(6), 1995, pp. 343-349
Authors:
SZCZEPANSKI M
DUCHINSKI T
KRETOWICZ P
Citation: M. Szczepanski et al., SINGLE-DOSE OF NANDROLONE DOES NOT PREVENT POSTOPERATIVE FIBRINOLYTICSHUTDOWN, Fibrinolysis, 9(6), 1995, pp. 350-355
Authors:
BASHKOV GV
JITKOVA JV
Citation: Gv. Bashkov et Jv. Jitkova, A COMBINATION OF RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE HAS A SYNERGISTIC NON-FIBRIN SPECIFIC ACTION ON IN-VITRO CLOT LYSIS, Fibrinolysis, 9(6), 1995, pp. 356-362
Authors:
BODDI M
PANICCIA R
COPPO M
BANDINELLI B
FRANCALANCI I
PRISCO D
ABBATE R
GENSINI GF
Citation: M. Boddi et al., EXERCISE-INDUCED TISSUE-PLASMINOGEN ACTIVATOR INCREASE - A ROLE FOR METABOLIC-ACIDOSIS, Fibrinolysis, 9(6), 1995, pp. 363-367
Authors:
LIPINSKI B
Citation: B. Lipinski, UNTITLED, Fibrinolysis, 9(6), 1995, pp. 368-368
Citation: RECENT LITERATURE ON FIBRINOLYSIS, Fibrinolysis, 9(5), 1995, pp. 13-13
Authors:
VANMEIJER M
PANNEKOEK H
Citation: M. Vanmeijer et H. Pannekoek, STRUCTURE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND ITS FUNCTION IN FIBRINOLYSIS - AN UPDATE, Fibrinolysis, 9(5), 1995, pp. 263-276
Authors:
THEURING F
AGUZZI A
KROPP C
WOHN KD
HOFFMANN S
SCHLEUNING WD
Citation: F. Theuring et al., ANALYSIS OF THE HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE PROMOTERACTIVITY DURING EMBRYOGENESIS OF TRANSGENIC MICE AND RATS, Fibrinolysis, 9(5), 1995, pp. 277-287